ABSTRACT
The highest viral loads of severe acute respiratory syndrome coronavirus-2 are detectable in the oral cavity, so a potential reduction of infectious virus by nasal and oral sprays could reduce transmission. Therefore, the inactivation capacity of nine nasal and oral sprays was evaluated according to EN 14476. One nasal spray based on sodium hypochlorite and one oral spray containing essential oils reduced viral titres by two to three orders of magnitude. Although clinical data are still sparse, nasal and oral sprays display a more convenient application for elderly people or those who are unable to rinse/gargle.
Subject(s)
COVID-19 , Nasal Sprays , Aged , Humans , Mouth , Mouthwashes , SARS-CoV-2ABSTRACT
Introduction: The ongoing SARS-CoV-2 pandemic creates a significant threat to global health. Recent studies suggested the significance of throat and salivary glands as major sites of virus replication and transmission during early COVID-19 thus advocating application of oral antiseptics. Objectives: Here, we evaluated the virucidal activity of different available oral rinses, nasal sprays as well as individual compounds found in oral rinses against SARS-CoV-2. These experiments were performed under conditions mimicking nasopharyngeal secretions and investigated their respective virucidal modes of action. Methods: According to European guidelines, virucidal activity was determined with a quantitative suspension test with 30 s exposure time on VeroE6 cells. Mechanistic analysis to reveal the mode of action of antiseptic agents included density gradient centrifugation and a capsid protection assay. Results: Three of the eight oral rinses as well as two nasal sprays significantly reduced viral infectivity to up to three orders of magnitude to background levels. Mechanistic analysis revealed that treatment with benzalconiumchloride and other antiseptic agents used in mouth rinses primarily disrupted the viral envelope, without affecting viral RNA integrity. Conclusion: In summary, we provide evidence that SARS-CoV-2 can be efficiently inactivated by commercially available oral rinses and nasal sprays with respect to their compound composition, within short exposure times, thus possibly lowering the transmission of SARS-CoV-2.
ABSTRACT
During the current SARS-CoV-2 pandemic new studies are emerging daily providing novel information about sources, transmission risks and possible prevention measures. In this review, we aimed to comprehensively summarize the current evidence on possible sources for SARS-CoV-2, including evaluation of transmission risks and effectiveness of applied prevention measures. Next to symptomatic patients, asymptomatic or pre-symptomatic carriers are a possible source with respiratory secretions as the most likely cause for viral transmission. Air and inanimate surfaces may be sources; however, viral RNA has been inconsistently detected. Similarly, even though SARS-CoV-2 RNA has been detected on or in personal protective equipment (PPE), blood, urine, eyes, the gastrointestinal tract and pets, these sources are currently thought to play a negligible role for transmission. Finally, various prevention measures such as handwashing, hand disinfection, face masks, gloves, surface disinfection or physical distancing for the healthcare setting and in public are analysed for their expected protective effect.